نتایج جستجو برای: xeloda

تعداد نتایج: 238  

Journal: :Anticancer research 2007
G P Stathopoulos J Koutantos H Lazaki S K Rigatos J Stathopoulos G Deliconstantinos

BACKGROUND Capecitabine (Xeloda) is a fluoropyrimidine which is transformed to 5-fluorouracil (5-FU) at the tumor site. The aim of the present study was to estimate the efficacy of this agent in pretreated patients with advanced breast and colorectal cancer, and to determine the response rate and adverse reactions. PATIENTS AND METHODS Forty-two patients (median age 65 years, range 27-80 year...

Journal: :Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2016
Calin Cainap Viorica Nagy Andrada Seicean Alexandra Gherman Istvan Laszlo Cosmin Lisencu Al Hajar Nadim Anne-Marie Constantin Simona Cainap

PURPOSE The purpose of this study was to evaluate the efficacy and toxicity of a third-generation chemotherapy regimen in the adjuvant setting to radically operated patients with gastric cancer. This proposed new adjuvant regimen was also compared with a consecutive retrospective cohort of patients treated with the classic McDonald regimen. METHODS Starting in 2006, a non-randomized prospecti...

Journal: :Bulletin of the National Research Centre 2022

Abstract Background ?-catenin is an important unit of the Wnt/?-catenin signaling pathway, a conserved process involving several physiological activities, encompassing differentiation and cell proliferation, etc. The dysfunction or mutation in causing initiation advancement various neoplasm types, including colorectal cancer, breast etc., has been reported. Therefore, therapeutic target. Hence,...

2015
Kazuyoshi Kawakami Eri Nakamoto Takashi Yokokawa Kazuo Sugita Yutarou Mae Akane Hagino Mitsukuni Suenaga Nobuyuki Mizunuma Sayaka Oniyama Yoshiaki Machida Toshiharu Yamaguchi Toshihiro Hama

BACKGROUND Capecitabine plus oxaliplatin (XELOX) has been established as a first-line treatment for metastatic colorectal cancer. Adherence is particularly important with capecitabine to maintain appropriate curative effect. In this study, we monitored the adherence to capecitabine on XELOX treatment and investigated which factors might decrease compliance. METHODS The study included 242 cons...

Journal: :Annals of Oncology 2023

Target therapy in metastatic colorectal cancer needs the determination of KRAS, NRAS, and BRAF mutation status to identify patients resistant anti-EGFR treatment. RASgenes (KRAS+NRAS) are mutated 40-50% 5-10%; presence a double RAS is very rare phenomenon, which why mutations considered exclusive each other. Herein, we describe novel concomitant NRAS/BRAF series patients. A 800 carcinomas fixed...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید